Patent classifications
C07C69/74
USE OF RUTHENIUM COMPLEXES IN OLEFIN METATHESIS REACTION
The invention relates to the use of ruthenium complexes, which are homogeneous catalysts and/or precatalysts of the olefin metathesis reaction, which lead to the production of alkenes containing an internal (non-terminal) double CC bond.
##STR00001##
Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof
The invention provides methods of synthesizing compounds in an asymmetric or enantioenriched fashion, wherein the compounds are useful intermediates in the synthesis of viral protease inhibitors.
Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof
The invention provides methods of synthesizing compounds in an asymmetric or enantioenriched fashion, wherein the compounds are useful intermediates in the synthesis of viral protease inhibitors.
LIQUID CRYSTAL COMPOSITION
A liquid crystal composition is provided containing a first liquid crystal compound represented by formula (1):
##STR00001##
and a second liquid crystal compound represented by formula (2):
##STR00002##
Also provided is a method for producing the liquid crystal composition having a desired wavelength dispersion characteristic.
Process for the preparation of organic bromides
The present invention provides a process for the preparation of organic bromides, by a radical bromodecarboxylation of carboxylic acids with a bromoisocyanurate.
Process for the preparation of organic bromides
The present invention provides a process for the preparation of organic bromides, by a radical bromodecarboxylation of carboxylic acids with a bromoisocyanurate.
TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
PRODRUGS OF GAMMA-HYDROXYBUTYRIC ACID, COMPOSITIONS AND USES THEREOF
The present disclosure discloses prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.
PRODRUGS OF GAMMA-HYDROXYBUTYRIC ACID, COMPOSITIONS AND USES THEREOF
The present disclosure discloses prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.